MetaCap

Myomo (MYO) vs Wallbox N.V. (WBX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

Myomo (MYO) has outperformed Wallbox N.V. (WBX) over the past year, gaining 23.3% versus a loss of 58.3%. Over five years, WBX leads with a -72.3% price change compared with -89.3% for MYO. Wallbox N.V. is the larger company by market cap ($67.2 million vs $56.6 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MYO+23.28%WBX-58.28%
+67%-2%-71%
Oct 9, 20251 yearOct 9, 2026
MYO-87.86%WBX-70.84%
+83%-11%-105%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MYO versus WBX key metrics
MetricMYOWBX
Share price$1.43$2.77
Market cap$56.64M$67.19M
1-day change+1.42%+1.09%
YTD return+57.14%+18.38%
1-year return+23.28%-58.28%
5-year return-89.28%-72.30%
EPS (TTM)$-0.35$-0.98
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.89$7.60
52-week low$0.605$2.30
Distance from 52-week high-24.14%-63.55%
Analyst consensusnonenone
Avg. price target upside+224.48%+44.40%
Average volume489.85K22.46K
Shares outstanding39.61M23.54M
Employees194594
SectorHealth CareConsumer Discretionary
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MYO has outperformed WBX by 81.6 percentage points over the past year.
  • The two companies sit in different sectors: Myomo in Health Care and Wallbox N.V. in Consumer Discretionary.

About Myomo

MYO stock →

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.

Health Care · Industrial Specialties · 194 employees

About Wallbox N.V.

WBX stock →

Wallbox N.V., a technology company, designs, manufactures, and distributes charging solutions for residential, business, and public applications in Europe, the Middle East, Asia, North America, and the Asia Pacific. It offers EV charging hardware products, such as Pulsar Plus, Pulsar Plus Socket, Pulsar Max, Pulsar Max Socket, Pulsar Pro, and Pulsar Pro Socket, and AC smart chargers for individual homes and shared spaces; Quasar 2, a DC bi-directional charger for home-use that allows to charge and discharge electric vehicle; Supernova, a DC fast charger equipment designed for public use; and Hypernova that allows to optimize available power and adapt to the number of EVs connected for public charging along highways and transcontinental road networks, as well as Wallbox ABL eM4 Single and Twin chargers and eMC3 charging pole.

Consumer Discretionary · Industrial Specialties · 594 employees

MYO vs WBX FAQ

Which is bigger, Myomo or Wallbox N.V.?

Wallbox N.V. (WBX) is larger, with a market capitalization of $67.19M compared with $56.64M for Myomo (MYO).

Which stock has performed better over the past year, MYO or WBX?

MYO returned +23.28% over the past 12 months, compared with -58.28% for WBX (price return, excluding dividends). Past performance does not predict future results.

Are Myomo and Wallbox N.V. in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons